Dongkook Pharmaceutical Launches Centellian24 "Madeca Cream Tight Lifting Red Rise Edition"
Dongkook Pharmaceutical announced on January 5 that it has launched a new product from its dermacosmetic brand Centellian24, the 'Madeca Cream Tight Lifting Red Rise Edition'.
The new product consists of two units of 'Madeca Cream Tight Lifting' (50ml each). This limited edition was planned to capture the energetic and dynamic spirit of the Year of the Red Horse, Byeongo Year.
'Madeca Cream Tight Lifting' is a multi-dimensional lifting anti-aging solution based on the concept of "slow aging," which aims to slow down the skin aging process and restore the skin to a healthier state.
It features a "three-step slow aging skin mechanism" that densely fills the skin barrier with moisture, firms up facial contours, and lifts the entire face. Through this, it comprehensively cares for skin elasticity and delivers a radiant glow even to bare skin. The limited edition package features a bold design with a rising sun in the background, visually expressing hopes for the new year and the meaning of a new leap forward for future changes.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Centellian24 representative stated, "This 'Madeca Cream Tight Lifting Red Rise Edition' was inspired by the dynamism and unstoppable energy symbolized by the 'Red Horse,'" adding, "We will continue to introduce anti-aging solutions tailored to consumers' skin concerns, including elasticity care, in the future."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.